glp-1 heart rate increase Differential effects of glucagon-like peptide-1 receptor agonists on | Cardiovascular Diabetology The conversation around GLP-1 medications

Physicians should balance the benefits and potential risks of semaglutide in their clinical decisions [63]

10.1210/clinem/dgae719 [DOI] [PMC free article] [PubMed] [Google Scholar] 19.Horowitz M, Rayner CK, Marathe CS, Wu T, Jones KL (2020) Glucagon-like peptide-1 receptor agonists and the appropriate measurement of gastric emptying

This is particularly important, as individuals with a history of self-harm or suicidal ideation could be most vulnerable to adverse psychiatric events related to GLP-1 receptor agonist use

Jiang, J

The patients who received the GLP-1 infusion had a significant improvement in left ventricular ejection fraction, VO2 max, and 6-minute walking distance

Furthermore, an important reduction in the number of deaths due to stroke was observed in the semaglutide treatment group (RR 0.49